store at low temperature
store at -80°C
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 123,500 |
2 mg | 在庫あり | ¥ 199,500 |
5 mg | 在庫あり | ¥ 342,000 |
10 mg | 在庫あり | ¥ 532,500 |
25 mg | 在庫あり | ¥ 794,000 |
ターゲット&IC50 | Eosinophils (human):0.9 pM(EC50), IL-5Rα:0.3nM, Basophils:0.5pM(EC50) |
別名 | BIW-8405, MEDI-563 |
分子量 | N/A |
CAS No. | 1044511-01-4 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Benralizumab 1044511-01-4 Apoptosis Immunology/Inflammation IL Receptor Interleukin MEDI 563 BIW 8405 BIW-8405 MEDI-563 BIW8405 MEDI563 Inhibitor inhibitor inhibit